Crataegutt® - WS® 1442
for decreasing cardiac performance corresponding to stage II according to NYHA.
Active ingredient:
Dry extract from Hawthorn leaves with flowers WS®1442
Crataegutt® contains the special extract WS® 1442 from Hawthorn leaves with flowers. This extract is standardized to contain 18.75% of oligomeric procyanidins (OPCs). Crataegutt® increases the strength of the cardiac muscle, reduces the work load of the heart and adapts cardiac activity to the organism's requirements. Crataegutt® promotes coronary and myocardial blood flow and improves the oxygen utilization of the heart. Crataegutt® leads to an increase in cardiac performance and physical capacity. Crataegutt® is well tolerated and should be taken over a longer period of time.
Approved indication in Germany:
Decreasing cardiac performance corresponding to stage II according to NYHA.
Note: If conditions persist, are unclear or new, consult a doctor as diseases requiring medical clarification might be involved.
For information on precautions for use, side effects and contra-indications see the package leaflet or contact your doctor or pharmacist.
Data based on information issued 2008/05